• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524742
INE475E01026
269.7614245
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CAPLIPOINT
38.89
15420.87
EPS(TTM)
Face Value()
Div & Yield %
52.17
2
0.2
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales191.36189.22175.18
Other Operating Income0.000.000.00
Other Income 61.0831.7359.22
Total Income252.44220.95234.40
Total Expenditure 107.7797.5099.33
PBIDT144.67123.45135.07
Interest 0.050.070.05
PBDT144.62123.38135.02
Depreciation6.906.376.02
Tax26.4529.3526.77
Fringe Benefit Tax0.000.000.00
Deferred Tax1.770.38-0.36
Reported Profit After Tax109.5087.28102.59
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item109.5087.28102.59
EPS (Unit Curr.)15.8911.4913.50
EPS (Adj) (Unit Curr.)15.8911.4913.50
Calculated EPS (Unit Curr.)14.4111.4813.50
Calculated EPS (Adj) (Unit Curr.)14.4111.4813.50
Calculated EPS (Ann.) (Unit Curr.)57.6345.9453.99
Calculated EPS (Adj) (Ann.) (Unit Curr.)57.6345.9453.99
Book Value (Unit Curr.)0.000.000.00
Dividend (%)200.000.000.00
Equity15.2015.2015.20
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)75.6065.2477.10
PBDTM(%)75.5765.2077.08
PATM(%)57.2246.1358.56